Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-24 | New | $14,402,880 | $14,402,880 | Equity Only | 06c | SEC link |
| 2019-12-20 | New | $8,555,000 | $8,555,000 | Equity and Debt | 06b | SEC link |
| 2019-07-31 | New | $2,805,000 | $2,805,000 | Debt Only | 06b | SEC link |
| 2018-07-03 | New | $1,077,000 | $1,077,000 | Equity and Debt | 06b | SEC link |
| Name | Role |
|---|---|
| Louis J. Basenese | Director |
| Anthony Di Giandomenico | Director |
| Sanjiv S. Gambhir | Director |
| Michael Harsh | Director |
| Richard Jacroux | Executive |
| Francois R. Michelon | Director, Executive |
| Michael Thornton | Executive |
| Alexander Tokman | Director, Executive |
| David R. Wells | Executive |